{
    "initial_questions": "Here are two multiple-choice questions for each Bloom's Taxonomy level:\n\n**Knowledge (Recall)**\n\n1) What is often the result when proteins in the body start misbehaving?\n    - A: The development of a new drug\n    - B: The discovery of new medicines\n    - C: Disease\n    - D: Genetic changes\n[Correct answer]: C\n\n2) How do researchers typically identify new therapeutic targets when studying DNA?\n    - A: By comparing genomes to spot patterns\n    - B: By focusing on a single protein\n    - C: By developing new drugs\n    - D: By studying the active chemicals in medicines\n[Correct answer]: A\n\n**Comprehension (Understanding)**\n\n1) What is the main goal of medical crowdsourcing in the context of drug development?\n    - A: To discover new, cheaper drugs for currently untreatable diseases\n    - B: To develop more effective and targeted treatments\n    - C: To understand the cause of a condition\n    - D: To identify the active chemicals in medicines\n[Correct answer]: A\n\n2) What approach are researchers now using to identify new therapeutic targets?\n    - A: Focusing on chance discoveries\n    - B: Using a more systematic approach by focusing on DNA\n    - C: Developing new drugs without considering genetic data\n    - D: Studying the active chemicals in medicines\n[Correct answer]: B\n\n**Application (Real-world scenarios)**\n\n1) How can a person with a currently untreatable disease contribute to the development of new treatments?\n    - A: By donating their genetic data and health history data\n    - B: By developing new drugs themselves\n    - C: By studying the active chemicals in medicines\n    - D: By comparing genomes to spot patterns\n[Correct answer]: A\n\n2) How can pharmaceutical companies use genetic data to improve treatment options?\n    - A: By developing more effective and targeted treatments\n    - B: By ignoring genetic data and focusing on traditional methods\n    - C: By selling genetic data to private companies\n    - D: By studying the active chemicals in medicines\n[Correct answer]: A\n\n**Analysis (Relationships, contrasts, cause-and-effect)**\n\n1) What is the relationship between genetic changes and disease?\n    - A: Genetic changes always lead to disease\n    - B: Genetic changes can lead to the production of malfunctioning proteins that cause disease\n    - C: Genetic changes have no impact on disease\n    - D: Disease causes genetic changes\n[Correct answer]: B\n\n2) What is the main difference between traditional drug development and medical crowdsourcing?\n    - A: Medical crowdsourcing involves a more systematic and targeted approach\n    - B: Traditional drug development involves a more systematic and targeted approach\n    - C: Medical crowdsourcing relies on chance discoveries\n    - D: Traditional drug development is more effective\n[Correct answer]: A\n\n**Synthesis (Combining ideas)**\n\n1) What could be the result of combining genetic data, health history data, and AI machine learning?\n    - A: The development of new, more effective treatments\n    - B: The discovery of new medicines by chance\n    - C: The identification of a single protein responsible for a disease\n    - D: The development of more expensive treatments\n[Correct answer]: A\n\n2) What could be the outcome of integrating genetic data and pharmaceutical companies?\n    - A: More targeted and effective treatments, but raises concerns about data protection and profit\n    - B: Less effective treatments, but no concerns about data protection and profit\n    - C: The development of new drugs without considering genetic data\n    - D: The identification of a single protein responsible for a disease\n[Correct answer]: A\n\n**Evaluation (Judgment, critique, justification)**\n\n1) Should pharmaceutical companies offer drugs more cheaply to individuals who donate their genetic data?\n    - A: Yes, it is a moral obligation\n    - B: No, it is not necessary\n    - C: Only if the individual requests it\n    - D: It depends on the specific circumstances\n[Correct answer]: A\n\n2) Is it ethical for private consumer genetic testing companies to sell genetic data to pharmaceutical companies for profit?\n    - A: Yes, it is a necessary step in developing new treatments\n    - B: No, it raises concerns about data protection and profit\n    - C: Only if the individual consents\n    - D: It depends on the specific circumstances\n[Correct answer]: B"
}